AccessMyLibrary provides FREE access to millions of articles from top publications available through your library.
Close
Create a link to this page
Copy and paste this link tag into your Web page or blog:
<a href="http://www.accessmylibrary.com/article-1G1-146740989/eli-lilly-seeks-expand.html" title="Facts and information about Eli Lilly seeks to expand indications for duloxetine (Cymbalta).(News Notes)(Brief article)">Eli Lilly seeks to expand indications for duloxetine (Cymbalta).(News Notes)(Brief article)</a>
Close
Set up an RSS feed that alerts you when new articles from The Brown University Geriatric Psychopharmacology Update are available.
Frequently asked questions about RSS feeds
Eli Lilly seeks to expand indications for duloxetine (Cymbalta).(News Notes)(Brief article)
Eli Lilly and Co. announced they will submit a supplemental New Drug Application (sNDA) to the FDA for Cymbalta (duloxetine) for treatment of generalized anxiety disorder. In the United States, Cymbalta …
Related articles from newspapers, magazines, journals, and more
-
- Statement from Eli Lilly and Co regarding approval recommendation from FDA...
-
News wire article from: Chemical Business Newsbase
August 19, 2010
700+ words
-
- Boehringer Ingelheim and Eli Lilly join up over Cymbalta.
-
News wire article from: Asia Africa Intelligence Wire
December 18, 2002
700+ words
-
- Eli Lilly's Cymbalta delayed again.
-
News wire article from: Asia Africa Intelligence Wire
September 10, 2003
700+ words
-
- Shionogi, Eli Lilly Japan to comarket Cymbalta.
-
News wire article from: Chemical Business Newsbase
May 3, 2010
700+ words
-
- Eli Lilly gets FDA approval for Cymbalta antidepressant.
-
News wire article from: Asia Africa Intelligence Wire
September 23, 2002
700+ words
